Final rule published
Specific Listing for 3-Chloromethcathinone, A Currently Controlled Schedule I Substance
Record date · Nov 6, 2026
What this means
- Status
- Final rule published
- What happened
- The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Controlled Substances Code Number (drug code) for 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3- chloromethcathinone; 3-CMC) in schedule I of the Controlled Substances Act (CSA). Although 3-chloromethcathinone is not specifically listed in schedule I of the CSA with its own unique drug code, it is a schedule I controlled substances in the United States because it is a…
- What to check next
- The published rule gives Nov 6, 2026 as its effective date. Check the official docket for later changes.
About this record
The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Controlled Substances Code Number (drug code) for 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3- chloromethcathinone; 3-CMC) in schedule I of the Controlled Substances Act (CSA). Although 3-chloromethcathinone is not specifically listed in schedule I of the CSA with its own unique drug code, it is a schedule I controlled substances in the United States because it is a positional isomer of 4-chloromethcathinone, which is a schedule I hallucinogen. Therefore, DEA is simply amending the schedule I hallucinogenic substances list in its regulations to separately include 3- chloromethcathinone.
Record details
- Federal Register document
- 2026-22717
- Stated effective date
- 2026-11-06
Sources and related records
Source checked .